Trending Investment Opportunities
Advertisement
Gainers
- Corvus Pharmaceuticals CRVS stock moved upwards by 53.98% to $3.48 during Friday's pre-market session. The company's market cap stands at $147.6 million.
- Innate Pharma IPHA shares rose 30.6% to $7.51. The company's market cap stands at $594.3 million. As per the news, the H1 earnings report came out 2 days ago.
- Surface Oncology SURF shares moved upwards by 14.47% to $6.88. The company's market cap stands at $312.7 million.
- BeiGene BGNE shares increased by 13.35% to $436.67. The market value of their outstanding shares is at $40.6 billion.
- Avalo Therapeutics AVTX shares moved upwards by 12.5% to $2.61. The market value of their outstanding shares is at $250.5 million.
- Gritstone Bio GRTS stock increased by 9.23% to $14.79. The market value of their outstanding shares is at $731.3 million.
Losers
- Protagonist Therapeutics PTGX shares fell 51.51% to $22.37 during Friday's pre-market session. The company's market cap stands at $1.0 billion.
- Syros Pharmaceuticals SYRS stock fell 9.91% to $4.91. The company's market cap stands at $304.0 million.
- Vera Therapeutics VERA shares decreased by 6.59% to $21.0. The company's market cap stands at $446.8 million.
- NanoVibronix NAOV shares declined by 6.2% to $1.97. The company's market cap stands at $47.4 million.
- Aileron Therapeutics ALRN shares declined by 4.63% to $1.03. The company's market cap stands at $93.2 million.
- Leap Therapeutics LPTX stock fell 4.35% to $2.42. The company's market cap stands at $144.4 million.
AVTXAvalo Therapeutics Inc
$6.117.93%
Edge Rankings
Momentum
11.48
Growth
N/A
Quality
N/A
Value
5.03
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.